Synthesis, Characterization and Biological Evaluation of Boronated Ionic Liquids for Potential BNCT Agents
- Author(s)
- 박샘이
- Issued Date
- 2018
- Abstract
- 최근 homogeneous 와 biphasic 과정에서 유기용매에 대한 친환경적인 훌륭한 대안으로 상온이온성액체에 대한 관심이 높아지고 있습니다. 상온이온성액체는 알킬 사슬 길이에 크게 영향을 받는 항균활성을 나타내는 것으로 알려졌다. 이번 연구에서, imidazolium과 N,N-dimethylaminopyridinium에 기반을 둔 이온성 액체를 다양한 보론음이온 (BF4−, BOB−, BMLB−, and dicarbollide와 같은)과 합성하였고, FT-IR, 1H, 11B, and 13C NMR을 통해 구조를 확인했다. 30μM와 다른 농도에서 이들의 생물학적평가를 진행하였다. 생체 외 연구는 붕소 이온성액체 유도체는 dicarbollide > BMLB− ≃ BOB− > BF4− 와 같은 순으로 독성이 나타났다. 다양한 이온성액체 중, 1-butyl-3-methylimidazolium tetrafluoroborate [C4MIM]BF4 이 다른 이온성액체에 비해 가장 낮은 독성을 보였다.|Room temperature ionic liquids (RTILs), a class of neoteric solvent have attracted increasing interest over recent years as environmentally benign excellent alternatives to organic solvents in homogeneous and biphasic processes. RTILs are also found to display anti-microbial activities being greatly affected by alkyl chain lengths. In the present investigation, certain imidazolium and N,N-dimethylaminopyridinium based ionic liquids with various boronated anions (such as BF4−, BOB−, BMLB−, and dicarbollide) were synthesized and the structures were confirmed by elemental and spectral studies such as FT-IR, 1H, 11B, and 13C NMR and they were screened for their biological evaluation against 30μM at different concentrations. In vitro studies of boronated ionic liquids derivatives could be summarized as decreasing in the order dicarbollide > BMLB− ≃ BOB− > BF4−. Among the various ionic liquids, 1-butyl-3-methylimidazolium tetrafluoroborate [C4MIM]BF4 was found to be less toxic than others.
- Alternative Title
- BNCT를 위한 붕소 화합물의 합성, 특성, 생물학적 평가
- Alternative Author(s)
- Park, Saem-I
- Department
- 일반대학원 화학과
- Advisor
- 이종대
- Awarded Date
- 2018-08
- Table Of Contents
- TABLE OF CONTENTS
TABLE OF CONTENTS
ⅰ
LIST OF FIGURES
ⅲ
LIST OF TABLE
ⅳ
국문해석
1
ABSTRACT
2
1.
Introduction.......................................................................................................
2.
Experimental Section.......................................................................................
2.1.
General considerations......................................................................................
2.2.
Cell viability assay (MTT assay)...................................................................
2.3.
In vitro boron incorporation into HCT116 cells..........................................
2.4.
Synthesis of ionic liquids based on 1-methylimidazole and 4-dimethylaminopyridine...................................................................................
2.4.1.
Synthesis of 1-alkyl-3-methylimidazolinium tetrafluoroborate......................
2.4.1.1.
1-Butyl-3-methylimidazolinium tetrafluoroborate............................................
2.4.1.2.
1-Pentyl-3-methylimidazolinium tetrafluoroborate..........................................
2.4.1.3.
1-Hexyl-3-methylimidazolinium tetrafluoroborate...........................................
2.4.2.
Synthesis of 1-alkyl-3-methylimidazolinium bis(oxalato)borate....................
2.4.2.1.
1-Butyl-3-methylimidazolinium bis(oxalato)borate.........................................
2.4.2.2.
1-Pentyl-3-methylimidazolinium bis(oxalato)borate........................................
2.4.2.3.
1-Hexyl-3-methylimidazolinium bis(oxalato)borate........................................
2.4.3.
Synthesis of 1-alkyl-3-methylimidazolinium bis(malonato)borate.................
2.4.3.1.
1-Butyl-3-methylimidazolinium bis(malonato)borate......................................
2.4.3.2.
1-Pentyl-3-methylimidazolinium bis(malonato)borate.....................................
2.4.3.3.
1-Hexyl-3-methylimidazolinium bis(malonato)borate.....................................
2.4.4.
Synthesis of 1-alkyl-4-dimethylaminopyridinium bis(oxalato)borate............
2.4.4.1.
1-Butyl-4-dimethylaminopyridinium bis(oxalato)borate..................................
2.4.4.2.
1-Pentyl-4-dimethylaminopyridinium bis(oxalato)borate................................
2.4.4.3.
1-Hexyl-4-dimethylaminopyridinium bis(oxalato)borate.................................
2.4.4.4.
1-Heptyl-4-dimethylaminopyridinium bis(oxalato)borate................................
2.4.5.
Synthesis of 1-alkyl-4-dimethylaminopyridinium bis(malonato)borate.........
2.4.5.1.
1-Butyl-4-dimethylaminopyridinium bis(malonato)borate...............................
2.4.5.2.
1-Pentyl-4-dimethylaminopyridinium bis(malonato)borate.............................
2.4.5.3.
1-Hexyl-4-dimethylaminopyridinium bis(malonato)borate..............................
2.4.5.4.
1-Heptyl-4-dimethylaminopyridinium bis(malonato)borate.............................
2.4.6.
Synthesis of 1-alkyl-3-methylimidazolinium dicarbollide..............................
2.4.6.1.
1-Butyl-3-methylimidazolinium dicarbollide...................................................
2.4.6.2.
1-Pentyl-3-methylimidazolinium dicarbollide..................................................
2.4.6.3.
1-Hexyl-3-methylimidazolinium dicarbollide..................................................
2.4.7.
Synthesis of 1-alkyl-4-dimethylaminopyridinium dicarbollide......................
2.4.7.1.
1-Butyl-4-dimethylaminopyridinium dicarbollide............................................
2.4.7.2.
1-Pentyl-4-dimethylaminopyridinium dicarbollide..........................................
2.4.7.3.
1-Hexyl-4-dimethylaminopyridinium dicarbollide...........................................
3.
Results and Discussion...................................................................................
3.1
Synthesis of boronated room temperature ionic liquids based on 1-methylimidazole.............................................................................................
3.2
Synthesis of boronated room temperature ionic liquids based on 4-dimethylaminopyridine...................................................................................
3.3
Synthesis of boronated room temperature ionic liquids based on carborane anion (dicarboliide).........................................................................
3.4
Biological activity of ionic liquids.................................................................
4.
Conclusion........................................................................................................
5.
References.........................................................................................................
- Degree
- Master
- Publisher
- 조선대학교 대학원
- Citation
- 박샘이. (2018). Synthesis, Characterization and Biological Evaluation of Boronated Ionic Liquids for Potential BNCT Agents.
- Type
- Dissertation
- URI
- https://oak.chosun.ac.kr/handle/2020.oak/13592
http://chosun.dcollection.net/common/orgView/200000266859
-
Appears in Collections:
- General Graduate School > 3. Theses(Master)
- Authorize & License
-
- AuthorizeOpen
- Embargo2018-08-24
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.